+Vote!
Contract Pharma Breaking News (Free subscription) | 24/11/2008
Bristol-Myers Squibb has exercised its option to develop and commercialize Exelixis Inc.'s IND candidate XL413, a selective inhibitor of Cdc7 targeting cancer cells. Under the terms of the collaboration agreement, BMS' selection of XL413 entitles Exelixis to a milestone payment of $20 million. In addition, Exelixis has exercised its option to co-develop and co-commercialize...
+Vote!
The East Bay Business Times (Free subscription) | 18/11/2008
Investment icon Carl Icahn has taken a stake in Bay Area drug-development companies Exelixis Inc. (EXEL) (BMY) (DNA) (LLY) (IMCL)
+Vote!
The San Francisco Business Times (Free subscription) | 07/11/2008
Drug-development company Exelixis Inc. will layoff 10 percent of its workforce — or 78 employees — as part of a restructuring plan. (EXEL) (DNA) (GSK) (BMY)
+Vote!
The East Bay Business Times (Free subscription) | 27/10/2008
Exelixis Inc. lost $38.5 million, or 36 cents per share, in the third quarter, compared with a $13.7 million loss, or 14 cents per share, in the same period last year. (EXEL) (GSK)
+Vote!
bizjournals (Free subscription) | 27/10/2008
Exelixis Inc. on Monday reported a widened third quarter loss of $38.5 million, or 36 cents a share, compared to a loss in the same period last year of $13.7 million, or 14 cents a share. (EXEL) (GSK)
+Vote!
Market Watch (Free subscription) | 17/11/2008
Billionaire investor Carl Icahn and his affiliates on Friday reported new stakes of 800,000 shares of Citigroup Inc. (C), 1.6 million shares of Advanced Micro Devices (AMD), and 461,128 shares of the Take-Two Interactive Software Inc. (TTWO) acquired during the third quarter.
+Vote!
Law Blog - WSJ.com (Free subscription) | 29/10/2008
... of cash or assets to generate cash" are in jeopardy, said George A. Scangos, chief executive of Exelixis Inc., a South San Francisco, Calif., biotech company.In the U.S., 38% of 370 small biotech companies are operating with less than a year's worth of cash, and nearly 100 publicly traded biotech companies have less than six months' cash, according to the Biotechnology Industry Organization...
+Vote!
EmailWire.Com (Free subscription) | 28/10/2008
(EMAILWIRE.COM, October 28, 2008 ) DALLAS, Texas Beacon Equity Research announces the release of Trade Alerts covering market movers: EcoloCap Solutions (OTCBB: ECOS), Align Technology Inc. (Nasdaq: ALGN), Inspire Pharmaceuticals Inc. (Nasdaq: ISPH), Silicon Image Inc. (Nasdaq: SIMG), Integrated...
